Placenta
Volume 31, Issue 3 , Pages 222-229 , March 2010

Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: Gestational diabetes mellitus, intrauterine growth restriction and preeclampsia

  • S.J. Holdsworth-Carson

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia
  • ,
  • R. Lim

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia
  • ,
  • A. Mitton

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia
  • ,
  • C. Whitehead

      Affiliations

    • Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash University, Clayton, Victoria 3168, Australia
  • ,
  • G.E. Rice

      Affiliations

    • Translational Proteomics, Baker IDI, Prahran, Victoria 3004, Australia
  • ,
  • M. Permezel

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia
  • ,
  • M. Lappas

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia
    • Mercy Perinatal Research Centre, Mercy Hospital for Women, Heidelberg, Victoria 3084, Australia
    • Translational Proteomics, Baker IDI, Prahran, Victoria 3004, Australia
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynaecology, University of Melbourne. Mercy Hospital for Women, Level 4/163 Studley Road, Heidelberg, Victoria 3084, Australia.

,Accepted 8 December 2009.

References 

  1. Barak Y, Liao D, He W, Ogn E, Nelson M, Olefsky J, et al. Effect of peroxisome proliferator-activated receptor d on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci U S A. 2002;99:303–308
  2. Barak Y, Nelson M, Ogn E, Jones Y, Ruiz-Lozano P, Chien K, et al. PPARγ is required for placental, cardiac, and adipose tissue development. Mol Cell. 1999;4:585–595
  3. Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl. 2):S112–S119
  4. Barger P, Browning A, Garner A, Kelly D. p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha – a potential role in the cardiac metabolic stress response. J Biol Chem. 2001;276:44495–44501
  5. Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28:67–80
  6. Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust N Z J Obstet Gynaecol. 1996;36:239–247
  7. Bensinger S, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008;454:470–477
  8. Bettinger BT, Gilbert DM, Amberg DC. Actin up in the nucleus. Nat Rev Mol Cell Biol. 2004;5:410–415
  9. Biron-Shental T, Schaiff WT, Ratajczak CK, Bildirici I, Nelson DM, Sadovsky Y. Hypoxia regulates the expression of fatty acid-binding proteins in primary term human trophoblasts. Am J Obstet Gynecol. 2007;197(516):e1–e6
  10. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol. 2000;40:133–138
  11. Buchanan TA, Kjos SL, Xiang A, Watanabe R. What is gestational diabetes?. Diabetes Care. 2007;30:S105–S111
  12. Camp H, Tafuri S. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem. 1997;272:10811–10816
  13. Catalano PM, Nizielski SE, Shao J, Preston L, Qiao L, Friedman JE. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab. 2002;282:E522–E533
  14. Chammas MF, Nguyen TM, Li MA, Nuwayhid BS, Castro LC. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?. Am J Obstet Gynecol. 2000;183:853–858
  15. Coughlan MT, Permezel M, Georgiou HM, Rice GE. Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes. J Clin Endocrinol Metab. 2004;89:3585–3594
  16. Delerive P, De Bosscher K, Vanden Berghe W, Fruchart J-C, Haegeman G, Staels B. DNA binding-independent induction of IκBa gene transcription by PPARα. Mol Endocrinol. 2002;16:1029–1039
  17. Deplanque D, Gele P, Petrault O, Six I, Furman C, Bouly M, et al. Peroxisome proliferator-activated receptor-a activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci. 2003;23:6264–6271
  18. Desai M, Han Guang, Ferelli M, Kallichanda N, Lane RH. Programmed upregulation of adipogenic transcription factors in intrauterine growth-restricted offspring. Reprod Sci. 2008;15:785–796
  19. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30(Suppl. 2):S120–S126
  20. Devchand R, Keller H, Peters J, Vazquez M, Gonzales F, Wahli W. The PPARa-leukotriene B4 pathway to inflammation control. Nature. 1996;384:39–43
  21. Ding N, Teng C, Ma H, Ni H, Ma X, Xu L, et al. Peroxisome proliferator-activated receptor delta expression and regulation in mouse uterus during embryo implantation and decidualization. Mol Reprod Dev. 2003;66:218–224
  22. Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K. Placental 11ß-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta. 2008;29:193–200
  23. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294:H541–H550
  24. Guaran RL, Wein P, Sheedy M, Walstab J, Beischer NA. Update of growth percentiles for infants born in an Australian population. Aust N Z J Obstet Gynaecol. 1994;34:39–50
  25. Hawfield A, Freedman BI. Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection. Ther Adv Cardiovasc Dis. 2009;3:65–73
  26. Hoffman L, Nolan C, Wilson JD, Oats JJ, Simmons D. Gestational diabetes mellitus–management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust. 1998;169:93–97
  27. Holdsworth-Carson SJ, Permezel M, Rice GE, Lappas M. Preterm and infection-driven preterm labor: the role of peroxisome proliferator-activated receptors and retinoid X receptor. Reproduction. 2009;137:1007–1015
  28. Holdsworth-Carson SJ, Permezel M, Riley C, Rice G, Lappas M. Peroxisome proliferator-activated receptors and retinoid X receptor-alpha in term human gestational tissues: tissue specific and labour-associated changes. Placenta. 2009;30:176–186
  29. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51:970–975
  30. Jansson EA, Are A, Greicius G, Kuo IC, Kelly D, Arulampalam V, et al. The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A. 2005;102:1460–1465
  31. Jawerbaum A, Capobianco E, Pustovrh C, White V, Baier M, Salzberg S, et al. Influence of peroxisome proliferator-activated receptorγ activation by its endogenous ligand 15-deoxy Δ12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women. Mol Hum Reprod. 2004;10:671–676
  32. Jawerbaum A, Gonzalez E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem. 2006;13:2127–2138
  33. Kenny L, Baker PN. Maternal pathophysiology in pre-eclampsia. Best Pract Res Clin Obstet Gynaecol. 1999;13:59–75
  34. Kliewer S, Xu H, Lambert M, Willson T. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res. 2001;56:239–265
  35. Lappas M, Permezel M, Geogiou H, Rice G. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod. 2002;67:668–673
  36. Lappas M, Permezel M, Rice G. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89:5627–5633
  37. Lappas M, Yee K, Permezel M, Rice G. Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kB and IkB kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology. 2005;146:1491–1497
  38. Lim H, Gupta R, Ma W, Paria B, Moller D, Morrow J, et al. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ. Genes Dev. 1999;13:1561–1574
  39. Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402–408
  40. Martinez N, Capobianco E, White V, Pustovrh MC, Higa R, Jawerbaum A. Peroxisome proliferator-activated receptor a activation regulates lipid metabolism in the feto-placental unit from diabetic rats. Reproduction. 2008;136:95–103
  41. Monk D, Moore GE. Intrauterine growth restriction–genetic causes and consequences. Semin Fetal Neonatal Med. 2004;9:371–378
  42. Oats JJ, McIntyre HD. Revision of guidelines for the management of gestational diabetes mellitus. Med J Aust. 2004;181:342
  43. Omar HA, Ramirez R, Arsich J, Tracy T, Glover D, Gibson M. Reduction of the human placental vascular relaxation to progesterone by gestational diabetes. J Matern Fetal Investig. 1998;8:27–30
  44. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506
  45. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41:437–445
  46. Rodie V, Young A, Jordan F, Sattar N, Greer I, Freeman D. Human placental peroxisome proliferator-activated receptor δ and γ expression in healthy pregnancy and in preeclampsia and intrauterine growth restriction. J Soc Gynecol Investig. 2005;12:320–329
  47. Schaiff W, Bildirici I, Cheong M, Chern P, Nelson D, Sadovsky Y. Peroxisome proliferator-activated receptor-γ and retinoid x receptor signaling regulate fatty acid uptake by primary human placental trophoblasts. J Clin Endocrinol Metab. 2005;90:4267–4275
  48. Sharma S, Adrogue J, Golfman L, Uray I, Lemm J, Youker K, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004;18:1692–1700
  49. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, et al. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003;100:9968–9973
  50. Staels B. PPAR agonists and the metabolic syndrome. Therapie. 2007;62:319–326
  51. Street M, Seghini P, Fieni S, Ziveri M, Volta C, Martorana D, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol. 2006;155:567–574
  52. Tarrade A, Schoonjans K, Pavan L, Auwerx J, Rochette-Egly C, Evain-Brion D, et al. PPARγ/RXRα heterodimers control human trophoblast invasion. J Clin Endocrinol Metab. 2001;86:5017–5024
  53. Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, et al. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta. Eur J Pharmacol. 2006;549:124–132
  54. Valmaseda A, Carmona MC, Barberá MJ, Viñas O, Mampel T, Iglesias R, et al. Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes. Mol Cell Endocrinol. 1999;154:101–109
  55. Waite L, Atwood A, Taylor R. Preeclampsia, an implantation disorder. Rev Endocr Metab Disord. 2002;3:151–158
  56. Waite L, Louie R, Taylor R. Circulating activators of peroxisome proliferator-activated recpetors are reduced in preeclamptic pregnancy. J Clin Endocrinol Metab. 2005;90:620–626
  57. Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260–1265
  58. Willson T, Lambert M, Kliewer S. Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem. 2001;70:341–367
  59. Yessoufou A, Hichami A, Besnard P, Moutairou K, Khan N. PPARα deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes melitus: modultion of T cell differentiation. Endocrinology. 2006;147:4410–4418
  60. Yiallourides M, Sebert S, Wilson V, Sharkey D, Rhind S, Symonds M, et al. The differential effects of the timing of maternal nutrient restriction in the ovine placenta on glucocorticoid sensitivity, uncoupling protein 2, PPAR-gamma and cell proliferation. Reproduction. 2009;138(3):601–608

PII: S0143-4004(09)00399-3

doi: 10.1016/j.placenta.2009.12.009

Placenta
Volume 31, Issue 3 , Pages 222-229 , March 2010